O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.
O2 RegenTech LLC is commercializing cost-effective, easy-to-use wound care solutions. Our proprietary, patented technology is used in our initial product offering, OXAID™, as an oxygenating, moist, and antimicrobial dressing to promote and accelerate chronic wound healing.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 26, 2017 | Grant | $600K | 2 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 14, 2021
Convosight
|
Series A | $9M | SaaS | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | — | Grant |
National Science Foundation | — | Grant |